preloder

長寿への投資

長寿のためのあらゆる生活条件
私たちは今あなたの人生を向上させる方法を知っています
分散型エコシステムの一部になる
グローバルな長寿

Private ICO round successfully completed.

1 LONGEVITY = 0,00001 ETH
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.
プロジェクトについて
地球規模の長寿は、質の高い長寿のためにあらゆる範囲の生活環境を作り出す、分散型のスケーラブルなエコシステムです。 それは世界の科学のすべての最新の成果を使用して、ブロックチェーン、ニューラルネットワークと機械学習に基づく寿命の個人化された管理のためにITプラットフォームで働きます。
LongevityソフトウェアトークンはGlobal Longevityによって生成され、その所有者に会社の現在および将来のサービスへのアクセスを提供します。 グローバル長寿は長寿市場で最高の技術と長年の経験を体現しています。

Longevity is Utility Token

非経済的なツールであるため、グローバル長寿サービスで購入できるグローバル長寿サービスおよび製品へのアクセスを所有者に提供します。

我々の使命

グローバル長寿の使命は、長寿技術の先端科学を利用して人々に命を伸ばす本当の機会を与えることです。

分散型エコシステムの一部になる

グローバルな長寿

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

生活の中でゲストにならないでください

彼女のホストになる!

私は永遠に生きることにしました。 そして、とても遠いすべてのものがうまくいきます。

作者不明

長期購入することができます

海の近くのアパートと土地(購入と賃貸)

魅力的なリゾート地やレクリエーション地域で不動産を購入したいという希望も、幅広い展望と機会をもたらします。 特に外国人の間で人気があるのは、ジョージア州 – アジャリア州、特にバトゥミ市 – 彼らが独特の風味を求めて行く港町 – です。

診断と治療

体の完全な診断は、特別な装置の助けを借りてそして様々なテストの提供を通して実行される包括的な検査を意味します。 得られたデータは、人間の健康状態、その内臓、そして良性と悪性の両方の新たな層の状態の全体像を描くことを可能にします。

法的支援

提供されるサービスの高い効率は私たちを導く原則によるものです。 これは専門家レベルの弁護士養成、各顧客への個人的なアプローチ、サービスの質に対する責任、彼らの校長の要望と関心に焦点を当てています。

薬理学的製品

この産業は研究、開発、大量生産、市場調査および医薬品の流通に関連しており、主に病気の予防、軽減および治療を目的としています。 現在、製薬業界は最も成功している業界の1つです。

グローバルな長寿のための有機食品

世界中で、有機食品の生産が急成長しています。 この食品には、現代の技術によって製造された製品と比較して、平均10〜50多いビタミン、ミネラル、その他の栄養素が含まれています。 有機食品は健康を増進し、免疫力を高め、そして特に子供、妊婦および授乳中の母親にとって有用です。

観光サービス

あなたが新鮮な風を吸いたい、鳥のさえずりと小川のせせらぎに目覚めたら、あなたは冒険の素晴らしい世界に飛び込みたいです – あなたは正しい場所に来ました!

鉱業

Global Longevityのこの分野での経験は、大手機器メーカーやテクノロジー企業とのパートナーシップの構築に役立ちました。これにより、将来的にお客様が採掘事業を遂行するのに成功することができます。

ICO&STOプロモーション

プロのスキルが適切に組み合わされて初めて、すべての目標を達成することができます。 私たちのチームのすべてのメンバーは、範囲に集中する熟練したプロです。

トークン
たとえ1Longevity(0,00001 ETH)のコストが0,001 ETHであったとしても、発行されたトークンの全量は私たちのグローバル長寿市場で提供される商品とサービスで完全に提供されます。 9900です。
Name: LONGEVITY
Ticker: LGV
Type: ERC-20
Platform: Ethereum
Token Type: Utility
Token Price: 0,00001 ETH
Soft Cap: none
Hard Cap: 1.000.000 LGV
Return on Invest: long-term token value increase
Purchase methods accepted: All Leading Crypto and Fiat
Total token supply: 100.000.000.000 LGV
Private-sale & Public Sale: 89.000.000.000 LGV
Team: 5.000.000.000 LGV
Advisors: 3.000.000.000 LGV
Marketing Activities and Bounty: 3.000.000.000 LGV

トークン分布のパーセンテージ

資金の割り当てと使用

NOTES

  • Team’s token will be locked for 30 months after the Private-sale & Public Sale
  • Tokens for Marketing team and Bounty will be locked for 6 months after the Private-sale & Public Sale
Investor Exclusions: Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia.
ロードマップ
Jan 2014
Official opening Global Longevity Institute
Mar 2014
Approval of the concept of creating an ecosystem within the program of Global Longevity
Nov 2014
Selection and approval of the region for the pilot project of Global Longevity
Jan 2015
Initiation of a material base for a pilot project of Global Longevity
May 2017
Completion of work on the creation of a material basis for the pilot project of Global Longevity
Jul 2017
Deciding on the implementation of blockchain and cryptocurrency in the project of Global Longevity
Jan 2018
Start preparation for ICO Global Longevity
Dec 2018
Cryptocurrency issue Longevity
May 2019
Start Pre ICO
Jun 2019
Start ICO
Jul 2021
Full launch of the Global Longevity project
チームとアドバイザー

Elina Mahzhalii

CEO (Chief Executive Officer),
CEO Global Longevity Institute

Wolfgang Stremmel

Professor of Internal Medicine IV

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

Akaki Lomadze

Doctor of Medicine, Male Health Expert

パートナー
ニュースと出版物
( 公開のために計画された公開 )
私達と連絡を取る

 

Global Longevity Disclaimer

Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.